15 August 2017 : Case report
Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer
Unusual setting of medical care, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)
DOI: 10.12659/AJCR.903528
Am J Case Rep 2017; 18:890-893
Metrics
Views & Downloads
Views: 540
Downloads: 3
Maximum downloads: 2 (2022.05)
Minimum downloads: 1 (2022.03)
Average monthly downloads: 0.5
Citation counts are provided from Web of Science and CrossRef. The counts may vary be service, and are reliant on availability of thier data. Counts will update daily once available.
SARS-CoV-2/COVID-19
29 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
07 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.936250
04 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.934468
In Press
09 Aug 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937172
09 Aug 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937609
09 Aug 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.936969
05 Aug 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937301
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report 
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399